✦ LIBER ✦

Islet transplantation: where do we stand now?

✍ Scribed by Boaz Hirshberg; Kristina I. Rother; David M. Harlan

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 56 KB
Volume: 19
Category: Article
ISSN: 1520-7552
DOI: 10.1002/dmrr.378

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification and system parameter esti

Identification and system parameter estimation; where do we stand now?

✍ P. Eykhoff; P.C. Parks 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Catastrophic antiphospholipid syndrome:

Catastrophic antiphospholipid syndrome: Where do we stand?

✍ Doruk Erkan; Ricard Cervera; Ronald A. Asherson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Vaccines against schistosomiasis: where

Vaccines against schistosomiasis: where do we stand?

✍ A.E. Butterworth 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 309 KB

Symposia in chromatography: Where do we

Symposia in chromatography: Where do we stand and where are we heading?

✍ Bertsch, Wolfgang 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Tuberculosis in children: Where do we go

Tuberculosis in children: Where do we go now?

✍ Jeffrey R. Starke 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

Where do we stand with hepatoblastoma? :

Where do we stand with hepatoblastoma? : A review

✍ J. Marco Schnater; S. Eleonore Köhler; Wouter H. Lamers; Dietrich von Schweinitz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

## Abstract Hepatoblastoma (HB) is the most common pediatric liver malignancy, comprising approximately 1% of all pediatric cancers. The disparate clinical staging systems and histologic classifications that were developed during the last decades, nevertheless, reflect the remaining difficulties an